Chugai Pharmaceutical Co., Ltd. (TYO:4519)

Chugai Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Operating Revenue	340,331	274,910	291,577	283,217	283,147	251,717	259,722	247,575	264,794	281,052	204,480	232,417	219,026	231,518	291,531	394,574	191,862	210,096	242,716	264,142
Other Revenue	64,412	66,674	30,170	63,084	50,029	38,287	28,737	54,498	50,884	34,859	32,469	41,395	38,871	35,899	20,709	43,922	33,422	25,516	117,838	58,124
Revenue	404,743	341,584	321,747	346,301	333,176	290,004	288,459	302,073	315,678	315,911	236,949	273,812	257,897	267,417	312,240	438,496	225,284	235,612	360,554	322,266
Revenue Growth (YoY)	21.48%	17.79%	11.54%	14.64%	5.54%	-8.20%	21.74%	10.32%	22.41%	18.13%	-24.11%	-37.56%	14.48%	13.50%	-13.40%	36.07%	-21.58%	6.41%	113.58%	53.15%
Cost of Revenue	119,093	104,218	92,790	87,559	100,240	88,068	87,823	94,301	84,218	87,940	72,950	92,060	78,256	91,662	151,329	212,908	69,096	79,823	114,424	110,556
Gross Profit	285,650	237,366	228,957	258,742	232,936	201,936	200,636	207,772	231,460	227,971	163,999	181,752	179,641	175,755	160,911	225,588	156,188	155,789	246,130	211,710
Selling, General & Admin	32,366	29,044	28,901	36,925	27,888	28,411	23,237	32,418	27,779	27,315	22,586	30,759	27,541	33,264	21,016	30,881	22,592	22,031	25,257	34,841
Research & Development	49,892	47,755	41,887	52,406	48,601	45,664	40,927	52,228	44,920	42,938	41,355	41,856	45,574	44,571	42,867	45,232	36,709	33,819	33,866	37,807
Other Operating Expenses	446	-291	-596	405	-38	-8,830	-178	-275	-1,645	-603	185	-12,439	-160	-14,694	-1,268	-	-	-	-	-
Operating Expenses	82,704	76,508	70,192	89,736	76,451	65,245	63,986	84,371	71,054	69,650	64,126	60,176	72,955	63,141	62,615	76,113	59,301	55,850	59,123	72,648
Operating Income	202,946	160,858	158,765	169,006	156,485	136,691	136,650	123,401	160,406	158,321	99,873	121,576	106,686	112,614	98,296	149,475	96,887	99,939	187,007	139,062
Interest Expense	-	-	-	-95	-58	-54	-	-	-	-1	3	-8	-7	-9	-2	-526	-15	-15	-14	-957
Interest & Investment Income	-	5,131	-	-	-	-	-	1,032	-	479	12	1,122	-	-	1,368	-	-	-	1,614	-
Other Non Operating Income (Expenses)	1,738	3,035	1,432	994	-356	-636	-821	1,074	-1,569	2	1	-	797	1,389	-1	267	-1,840	789	-2,401	335
Pretax Income	204,684	169,024	160,197	169,905	156,071	136,001	135,829	125,507	158,837	158,801	99,889	122,690	107,476	113,994	99,661	149,216	95,032	100,713	186,206	138,440
Income Tax Expense	61,131	52,693	44,779	41,495	44,858	38,846	38,595	33,948	49,341	46,941	25,488	31,484	29,903	30,801	26,161	46,737	27,235	28,335	54,431	39,599
Earnings From Continuing Operations	143,553	116,331	115,418	128,410	111,213	97,155	97,234	91,559	109,496	111,860	74,401	91,206	77,573	83,193	73,500	102,479	67,797	72,378	131,775	98,841
Net Income	143,553	116,331	115,418	128,410	111,213	97,155	97,234	91,559	109,496	111,860	74,401	91,206	77,573	83,193	73,500	102,479	67,797	72,378	131,775	98,841
Net Income to Common	143,553	116,331	115,418	128,410	111,213	97,155	97,234	91,559	109,496	111,860	74,401	91,206	77,573	83,193	73,500	102,479	67,797	72,378	131,775	98,841
Net Income Growth (YoY)	29.08%	19.74%	18.70%	40.25%	1.57%	-13.15%	30.69%	0.39%	41.15%	34.46%	1.23%	-11.00%	14.42%	14.94%	-44.22%	3.68%	-21.18%	2.34%	177.94%	88.96%
Shares Outstanding (Basic)	1,645	1,646	1,646	1,646	1,646	1,646	1,646	1,646	1,645	1,645	1,645	1,645	1,645	1,645	1,645	1,645	1,645	1,645	1,644	1,644
Shares Outstanding (Diluted)	1,645	1,646	1,646	1,646	1,646	1,646	1,646	1,646	1,646	1,646	1,646	1,645	1,646	1,645	1,645	1,645	1,645	1,645	1,645	1,645
Shares Change (YoY)	-0.03%	-0.00%	-0.00%	-0.03%	-0.01%	0.00%	0.01%	0.06%	0.02%	0.01%	0.01%	-0.00%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%
EPS (Basic)	87.25	70.69	70.13	78.04	67.58	59.04	59.09	55.62	66.54	67.98	45.22	55.43	47.15	50.57	44.68	62.30	41.21	44.00	80.14	60.11
EPS (Diluted)	87.25	70.69	70.13	78.03	67.58	59.04	59.08	55.62	66.53	67.97	45.21	55.43	47.14	50.56	44.67	62.28	41.20	43.99	80.09	60.08
EPS Growth (YoY)	29.11%	19.74%	18.70%	40.30%	1.58%	-13.14%	30.68%	0.33%	41.13%	34.43%	1.21%	-10.99%	14.42%	14.94%	-44.22%	3.66%	-21.19%	2.33%	177.90%	88.97%

Additional Metrics

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Free Cash Flow	21,733	118,531	109,343	111,736	61,112	92,583	44,576	152,588	106,119	50,156	88,536	106,412	22,378	108,628	100,559	-38,966	18,126	163,905	38,422	87,127
Free Cash Flow Per Share	13.21	72.03	66.44	67.89	37.13	56.26	27.09	92.69	64.48	30.48	53.80	64.68	13.60	66.02	61.12	-23.68	11.02	99.62	23.35	52.96
Dividend Per Share	-	66.000	-	72.000	-	50.000	-	57.000	-	41.000	-	80.000	-	40.000	-	40.000	-	38.000	-	46.000
Dividend Growth (YoY)	-	32.00%	-	26.32%	-	21.95%	-	-28.75%	-	2.50%	-	100.00%	-	5.26%	-	-13.04%	-	26.67%	-	53.33%
Gross Margin	70.58%	69.49%	71.16%	74.72%	69.91%	69.63%	69.55%	68.78%	73.32%	72.16%	69.21%	66.38%	69.66%	65.72%	51.53%	51.45%	69.33%	66.12%	68.26%	65.69%
Operating Margin	50.14%	47.09%	49.34%	48.80%	46.97%	47.13%	47.37%	40.85%	50.81%	50.12%	42.15%	44.40%	41.37%	42.11%	31.48%	34.09%	43.01%	42.42%	51.87%	43.15%
Profit Margin	35.47%	34.06%	35.87%	37.08%	33.38%	33.50%	33.71%	30.31%	34.69%	35.41%	31.40%	33.31%	30.08%	31.11%	23.54%	23.37%	30.09%	30.72%	36.55%	30.67%
Free Cash Flow Margin	5.37%	34.70%	33.98%	32.27%	18.34%	31.92%	15.45%	50.51%	33.62%	15.88%	37.36%	38.86%	8.68%	40.62%	32.21%	-8.89%	8.05%	69.57%	10.66%	27.04%
EBITDA	203,646	161,558	159,265	200,441	156,785	137,091	137,050	153,866	160,806	158,721	100,273	129,511	107,086	113,064	98,796	157,334	104,604	100,239	187,307	146,779
EBITDA Margin	50.31%	47.30%	49.50%	57.88%	47.06%	47.27%	47.51%	50.94%	50.94%	50.24%	42.32%	47.30%	41.52%	42.28%	31.64%	35.88%	46.43%	42.54%	51.95%	45.55%
D&A For EBITDA	700	700	500	31,435	300	400	400	30,465	400	400	400	7,935	400	450	500	7,859	7,717	300	300	7,717
EBIT	202,946	160,858	158,765	169,006	156,485	136,691	136,650	123,401	160,406	158,321	99,873	121,576	106,686	112,614	98,296	149,475	96,887	99,939	187,007	139,062
EBIT Margin	50.14%	47.09%	49.34%	48.80%	46.97%	47.13%	47.37%	40.85%	50.81%	50.12%	42.15%	44.40%	41.37%	42.11%	31.48%	34.09%	43.01%	42.42%	51.87%	43.15%
Effective Tax Rate	29.87%	31.18%	27.95%	24.42%	28.74%	28.56%	28.41%	27.05%	31.06%	29.56%	25.52%	25.66%	27.82%	27.02%	26.25%	31.32%	28.66%	28.13%	29.23%	28.60%
Revenue as Reported	404,743	-	321,747	-	333,177	-	288,459	-	315,678	-	-	-	-	-	-	-	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error